Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma

Gamma delta (γδ) T cells are critical for tissue immune surveillance and their presence in tumors correlates with a favorable prognosis, highlighting their therapeutic potential. Although γδ T cells are abundant in the skin, their therapeutic value in skin cancer has remained largely unexplored due to challenges in isolating sufficient numbers of γδ T cells from human tissues and a lack of suitable preclinical models for skin cancer. Here, we are using innovative methods to expand human cutaneous γδ T cells ex vivo, enabling us to investigate their therapeutic potential in a human cutaneous squamous cell carcinoma (cSCC) mouse model. In this model, γδ T cells were specifically recruited to and maintained in the cSCC xenograft. These tumor-infiltrating cells exhibited an activated, cytotoxic phenotype and demonstrated effective antitumor activity in vivo. Collectively, our findings provide preclinical evidence supporting human skin-resident γδ T cells as a promising immunotherapeutic approach for treating skin cancers such as cSCC.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2026-06-24
DOI
https://doi.org/10.1126/sciadv.aec7215
Primary Topic
T-cell and B-cell Immunology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma

Christina Guttmann‐Gruber, Oliver Nussbaumer, Teresa Burner, Martin Laimer et al.
Science Advances
T-cell and B-cell Immunology
article

Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma

Christina Guttmann‐Gruber, Oliver Nussbaumer, Teresa Burner, Martin Laimer, Iris K. Gratz, Roland Zauner, Giorgia Nasi, Monika Ettinger, Suraj R. Varkhande, Anshu Sharma, Teodora Aleksandrova, Andrew Hutton, Lara Ronacher, Amalia Sophianidis, Johanna Moser-Waxenecker, Leonie C. Schöftner, Julia Feiser
article en

Abstract

Gamma delta (γδ) T cells are critical for tissue immune surveillance and their presence in tumors correlates with a favorable prognosis, highlighting their therapeutic potential. Although γδ T cells are abundant in the skin, their therapeutic value in skin cancer has remained largely unexplored due to challenges in isolating sufficient numbers of γδ T cells from human tissues and a lack of suitable preclinical models for skin cancer. Here, we are using innovative methods to expand human cutaneous γδ T cells ex vivo, enabling us to investigate their therapeutic potential in a human cutaneous squamous cell carcinoma (cSCC) mouse model. In this model, γδ T cells were specifically recruited to and maintained in the cSCC xenograft. These tumor-infiltrating cells exhibited an activated, cytotoxic phenotype and demonstrated effective antitumor activity in vivo. Collectively, our findings provide preclinical evidence supporting human skin-resident γδ T cells as a promising immunotherapeutic approach for treating skin cancers such as cSCC.

Science AdvancesVol. 12(26)
Johannes Kepler University of Linz (AT), University of Salzburg (AT), Paracelsus Medical University (AT), Kepler Universitätsklinikum (AT), Unfallkrankenhaus Salzburg (AT), EB House Austria (AT), Benaroya Research Institute, Takeda (Japan) (JP)
Francis Crick Institute, King's College London, Austrian Science Fund, Universität Salzburg, Paracelsus Medizinische Privatuniversität
Good health and well-being
Openalex Percentile: Top 10%
T-cell and B-cell Immunology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.